Want to join the conversation?
$VSAT said since the company is now building versus buying the payloads, the start of the construction program involves significant new R&D expenses that began impacting Adjusted EBITDA performance in its commercial segment this fiscal year; ViaSat-3 class satellite construction expenses are expected to grow in future quarters, the company added.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.